A-Rod is going to try to put bud Selig and Randy Levine on the stand, but don’t count on it happening

25 Comments

Ken Davidoff of the New York Post reports that, when the arbitration resumes next week, Alex Rodiguez’s lawyers are going to try to put Bud Selig and Yankees president Randy Levine on the stand. MLB would probably fight that, though:

MLB would try to block most of the bold-name witnesses from having to testify, particularly Selig. It would contend MLB COO Rob Manfred, who is MLB’s representative on the three-person panel overseeing the hearing, spoke on behalf of the league and its investigation and subjected himself to cross-examination by Rodriguez’s attorney, Joseph Tacopina.

Like any other case, the decision should come down to whether or not Selig and Levine have relevant evidence. In a legal context, though, relevant doesn’t mean “interesting” or “headline grabbing.” It means evidence having any tendency to make the existence of any fact that is of consequence to the determination of the action more probable or less probable than it would be without the evidence.

I seriously question whether Selig has any relevant evidence to provide. He’s the boss, sure, but that doesn’t mean he has actual specific information that cannot be better obtained from other witnesses, such as Rob Manfred or MLB investigators. Bud puts things in motion. Other people do the work and they report it back to him. Anything he has that relates specifically to the drugs Alex Rodriguez took or didn’t take and the Biogenesis investigation in general was told to him.

Of course A-Rod is trying to put MLB on trial here. He’s trying to argue that the whole investigation was cooked up as a means of Selig doing P.R. damage control or saving his legacy or what have you and that, as a result, he should get to grill Selig about it all. Same with Levine and the Yankees trying to end his career and save millions. We’ve heard A-Rod’s attorneys argue this in public before.

And there may be elements of truth to that. I personally think that, even though Biogenesis and A-Rod’s drug use wasn’t “cooked up” by Selig, he’s certainly trying to take advantage of it as a means of putting an end to the PED saga. And I am certain that the Yankees would love to be out from under A-Rod’s contract.  But I seriously doubt that the arbitrator is going to let A-Rod try that case. That’s one for the historians and, if we really stretch things, a federal court to later weigh in on in the event such motives caused MLB and the Yankees to violate A-Rod’s rights. It’s not what this arbitration is about. Or at least what it should be about.

Upshot: don’t bank on Selig getting cross-examined.

Report: Adam Eaton to miss rest of the season with a torn ACL

Getty Images
1 Comment

It’s been a miserable weekend for Nationals’ outfielder Adam Eaton, who stumbled over first base and injured his leg while running out an infield single in Friday’s 4-3 win over the Mets. While the team officially placed the outfielder on the 10-day disabled list with a left knee strain on Saturday, FOX Sports’ Ken Rosenthal reports that Eaton has been diagnosed with a torn ACL in his left knee and is expected to miss the remainder of the 2017 season. The team has yet to confirm the diagnosis or announce a definite timetable for the 28-year-old’s return, perhaps due to extended evaluations by Eaton’s orthopedic doctor:

The Nationals appear to have several outfield options with Eaton on the disabled list, though they have not pinned down a long-term solution. Center fielder Michael Taylor replaced Eaton on the field during the tail end of Friday’s game, and returned on Saturday to man center and bat second in the lineup. The club also promoted top outfield prospect Rafael Bautista, who slashed .291/.325/.354 with five doubles and a .680 OPS through 19 games in Triple-A Syracuse this season. He’ll assume Eaton’s roster spot and looks to be available for a backup role in the outfield going forward.

Shelby Miller will undergo Tommy John surgery

Getty Images
1 Comment

Last we heard from Shelby Miller, the Diamondbacks’ right-hander was contemplating Tommy John surgery for a partial UCL tear in his right elbow. Now, he appears to have decided to go through with the procedure.

Miller decided to skip Tommy John alternatives like plasma-rich platelet injections or stem cell treatment, which have been used to varying degrees of success by other major league pitchers with similar injuries. The surgery will set him back an estimated 12-18 months, FanRag Sports’ Tommy Stokke reports, which puts Miller’s estimated return date somewhere in 2018 if all goes well.

The 26-year-old starter was off to a rocky start this season, posting a 2-2 record and 4.09 ERA through 22 innings and striking out just 20 of 99 batters faced. This was his sophomore campaign in Arizona after muddling through the 2016 season with a 3-12 record, 6.15 ERA and 0.5 fWAR over 101 innings with the club.